title: [KCC2: a new therapeutical target for the treatment of neurological diseases].
authors.affiliation: Centre de recherche de l'Institut universitaire en santé mentale de Québec, 2601, de la Canardière, G1J 2G3 Québec, Canada.
authors.forename: Marc J
authors.initials: MJ
authors.lastname: Bergeron
authors.affiliation: Centre de recherche de l'Institut universitaire en santé mentale de Québec, 2601, de la Canardière, G1J 2G3 Québec, Canada.
authors.forename: Annie
authors.initials: A
authors.lastname: Castonguay
authors.affiliation: Centre de recherche de l'Institut universitaire en santé mentale de Québec, 2601, de la Canardière, G1J 2G3 Québec, Canada.
authors.forename: Yves
authors.initials: Y
authors.lastname: De Koninck
mesh_terms: D000700:Analgesics / Q000627:therapeutic use*; D000818:Animals; D001921:Brain / Q000187:drug effects / Q000378:metabolism; D006801:Humans; D058990:Molecular Targeted Therapy; D009422:Nervous System Diseases / Q000188:drug therapy* / Q000235:genetics / Q000378:metabolism; D011355:Prodrugs / Q000627:therapeutic use; D051381:Rats; D027981:Symporters / Q000502:physiology*; D053778:Thiazolidines / Q000627:therapeutic use*; D000096922:K Cl- Cotransporters
chemical_list: D000700:Analgesics; D011355:Prodrugs; D027981:Symporters; D053778:Thiazolidines; D000096922:K Cl- Cotransporters; C585828:CLP257